Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vizgen logo — Confidently take your research to new depths with MERSCOPE U...

Vizgen

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis

Founded 2019 United States Cambridge, United States 153 employees Series E Total: $184.20M Biotechnology, Health Care +1

General Information

Company Name Vizgen
Founded Year 2019
Location United States Cambridge, United States
Employees 153
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series E
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Vizgen. To contact Vizgen, visit vizgen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Vizgen

Vizgen, a frontrunner in the spatial biology sector, is making waves with its innovative MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics. Following its merger with Ultivue, the company has positioned itself at the forefront of spatial multiomics analysis, integrating advanced tools such as high-fidelity InSituPlex® assays and AI-driven STARVUE™ spatial image analysis technology.

Founded in 2019 and headquartered in the United States, Vizgen aims to revolutionize the fields of Biotechnology, Health Care, and Life Sciences by providing researchers with the tools needed to uncover profound insights into human biology. Recognized as the #1 private spatial biology company of 2024 by Genetic Engineering & Biotechnology News, their technology delivers high-precision data conducive to both foundational and clinical research.

In terms of financial backing, Vizgen received a substantial $48.00M Series E investment on 01 January 2026 from notable investors such as Arch Venture Partners, M Ventures, and Northpond Ventures.

Taxonomy: single-cell spatial genomics, spatial multiomics, MERFISH technology, MERSCOPE Platform, InSituPlex assays, AI-driven spatial image analysis, translational research, high-fidelity data, quantitative data analysis, spatial biology, multi-omics research, genome-scale nucleic acid imaging, subcellular resolution, drug development, biotech innovation

Services & Products

Spatial Transcriptomics Services
Spatial Proteomics Services
Spatial Omics Services
Custom Biomarker Panels
Data Analysis with STARVUE

Target Customers

Molecular Labs Researchers in Neuroscience Oncology Researchers Immunology Researchers Academic Institutions Biotech Companies

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series E $48.00M 3
Arch Venture Partners M Ventures Northpond Ventures
Arch Venture Partners, M Ventures +1
01 Jan 2026
Series C $85.20M 7
Arch Venture Partners Tao Capital Partners Northpond Ventures
Arch Venture Partners, Tao Capital Partners +5
01 Jun 2022
Series B $37.00M 6
Arch Venture Partners Pura Vida Investments Tao Capital Partners
Arch Venture Partners, Pura Vida Investments +4
01 Apr 2021
Series A $14.00M 2
Arch Venture Partners Northpond Ventures
Arch Venture Partners, Northpond Ventures
01 Jan 2020
Spinout Undisclosed 1
Harvard University
01 Mar 2019

Vizgen Alternatives & Competitors

Vizgen vs
NanoString Technologies, Inc.
NanoString Technologies, Inc. United States

Mapping the universe of biology 🧬

IPO
225 employees
Biotechnology, Health Care
Compare Vizgen vs NanoString Technologies, Inc.
Vizgen vs
Mission Bio
Mission Bio United States

The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at sin...

Growth
88 employees
Biotechnology, Health Care
Vizgen vs
Intek Scientific Inc.
Intek Scientific Inc. United States

Developing innovative biomarker imaging technologies and biomedical devices

Non Equity Assistance
1 employees
Health Care, Life Sciences

FAQ About Vizgen

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis
Vizgen was founded in 2019.
Vizgen is headquartered in Cambridge, United States.
Vizgen operates in Biotechnology, Health Care and Life Sciences. Its work centres on single-cell spatial genomics, spatial multiomics, MERFISH technology and MERSCOPE Platform. Its customers include Molecular Labs, Researchers in Neuroscience and Oncology Researchers.
Vizgen has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Service Fee and Subscription.
Vizgen has approximately 153 employees.
Vizgen has completed 5 funding rounds, raising a total of $184.20M. The latest funding stage is Series E.
Vizgen offers: Spatial Transcriptomics Services, Spatial Proteomics Services, Spatial Omics Services, Custom Biomarker Panels, Data Analysis with STARVUE.
Top alternatives and competitors to Vizgen include NanoString Technologies, Inc., Mission Bio, Intek Scientific Inc., Earlham Institute, Akoya Biosciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vizgen and NanoString Technologies, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vizgen, https://bouncewatch.com/company/vizgen, updated 4 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes